相关实验视频

Updated: Jun 4, 2025

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

在成年T细胞白血病-淋巴瘤复发中的25年克隆复活

Atae Utsunomiya¹, Jun-Ichirou Yasunaga², Tomohisa Tabuchi³

¹Department of Hematology, Imamura General Hospital, 11-23, Kamoikeshinmachi, Kagoshima, 890-0064, Japan. autsunomiya@jiaikai.jp.

International journal of hematology

|December 24, 2024

概括

这项研究详细介绍了一种罕见的复发性成人T细胞白血病淋巴瘤 (ATL) 病例,在最初诊断和缓解26年后,相同的人类T细胞白血病病毒1型 (HTLV-1) 克隆导致复发.

科学领域:

血液学血液学血液学
在瘤学瘤学.
病毒学病毒学

背景情况:

成人T细胞白血病-淋巴瘤 (ATL) 是一种侵略性的恶性瘤.
在ATL中可能发生复发,但长期的克隆性持续性不明.
人类T细胞白血病病毒1型 (HTLV-1) 是ATL的致病原体.

研究的目的:

报告一个罕见的ATL复发病例,经过26年的缓解.
为了调查复发的ATL的克隆起源.
为了确定患者中HTLV-1感染克隆的长期存活率.

主要方法:

嵌套PCR用于放大ATL克隆特异性DNA.
从血素和素染色淋巴瘤样本中分析DNA.
从外围血液单核细胞和淋巴瘤细胞中测序安普利康.

主要成果:

在26年前的外周血液和原始淋巴瘤组织中发现了相同的ATL克隆.
复发的ATL克隆存在于四分之一世纪前诊断的瘤细胞中.
这是第一份关于在复发性ATL病例中感染HTLV-1的克隆26年生存的报道.

结论:

在患有ATL的患者中,HTLV-1感染的克隆可以持续至少26年.
长期的克隆性持久性可能会导致ATL晚期复发.
这一案例凸显了在公开ATL之前惰的HTLV-1克隆存活的潜力.

关键词:

ATL ATL 在线播放在 ATL 克隆特定的整合中.感染HTLV-1的克隆病毒的长存期.

更多相关视频

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

相关概念视频

Cells of the Adaptive Immune Response

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...